» Articles » PMID: 31415498

Completeness of ANZACS-QI Cardiac Implanted DEVICE Registry and Agreement with National Datasets: ANZACS-QI 30

Overview
Journal N Z Med J
Specialty General Medicine
Date 2019 Aug 16
PMID 31415498
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The ANZACS-QI Cardiac Implanted Device Registry (ANZACS-QI DEVICE) collects data on cardiac implantable electronic devices inserted in New Zealand. We evaluated completeness of data capture and quality of ANZACS-QI DEVICE in 2016.

Methods: Complete datasets within ANZACS-QI DEVICE, comprising DEVICE-PPM (permanent pacemakers) and DEVICE-ICD (implantable cardioverter defibrillators), from 1 January 2016 to 31 December 2016 were linked with the National Hospitalisation dataset (all New Zealand public hospital admissions). The total number of implants included procedures captured in either dataset. Variables assessed included age, gender, ethnicity, procedure type, implanting centre, admission and procedure date.

Results: DEVICE-PPM captured 85.9% of all PPM procedures (n=2,512). This was similar regardless of age, sex and ethnicity. In the 84.4% of procedures captured in both datasets, agreement was >97% for all variables except admission date (90.1%). DEVICE-ICD captured 81.3% of all ICD procedures (n=690). Capture was similar across age, sex and ethnicity groups. In the 76.8% of procedures captured in both datasets, agreement was >96% for all variables except admission date (90.6%).

Conclusion: The ANZACS-QI DEVICE registry had a good capture rate and excellent agreement with the national dataset. This high concordance supports the use of both datasets for future research.

Citing Articles

Statement from the Asia Summit: Current state of arrhythmia care in Asia.

Shimizu W, Kusumoto F, Agbayani M, Apiyasawat S, Chen M, Ching C Heart Rhythm O2. 2023; 4(11):741-755.

PMID: 38034890 PMC: 10685152. DOI: 10.1016/j.hroo.2023.08.005.


Dependence on permanent pacemakers inserted after transcatheter aortic valve implantation: predictive factors in a ten-year retrospective analysis: Rates and predictors of pacemaker dependence after TAVI.

Ng L, Nair R, Ali F, Pasupati S AsiaIntervention. 2021; 7(2):98-102.

PMID: 34913013 PMC: 8658553. DOI: 10.4244/AIJ-D-21-00020.


Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS-QI 33).

Foo F, Lee M, Looi K, Larsen P, Clare G, Heaven D J Arrhythm. 2020; 36(1):153-163.

PMID: 32071634 PMC: 7011834. DOI: 10.1002/joa3.12244.